NOV 12, 2020 1:30 PM PST

Covid-19 Testing and the role of Antigen assays today and moving forward

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Laboratory Director, Sherman Abramas Laboratory
    Biography

      I have the expertise, leadership, training, and motivation necessary to successfully carry out the proposed research project.  I have a broad background in biology, with specific training and expertise in public health microbiology, particularly pertaining to serological responses to infectious diseases, including emerging infectious diseases.  My work includes clinical laboratory diagnostics research across a broad range of disciplines.  My particular focus currently is development and evaluation of high-quality clinical laboratory diagnostic tests, particularly for emerging or under-studied pathogens. Presently, work in our laboratory is focused on evaluation and development of serological assays for detection of antibodies against SARS-CoV-2.



      My early publications addressed the role of mobile genetic elements in human cancers. My work has led to several novel findings in the field, including the clonal variation of human mobile elements in different cancers, the contribution of mobile elements to DNA double strand break repair, description of the extensive variation in full-length/active mobile elements between individuals, and the role of several DNA repair pathways, including nucleotide excision repair and transcription-coupled repair, in limiting damage from mobile elements in vivo. Additionally, my work developed several novel tools that are now widely used in the field of mobile elements including a high-throughput sequencing approach for mobile element identification, and a droplet digital PCR approach for detection of rare mobile element insertions in tumors.



      Additionally, I have made substantial contributions to the field of infectious diseases through work on the human parasite Plasmodium falciparum where my work focused on identifying potential druggable targets in the malaria parasite. Together with collaborators, I have described a receptor activated kinase required for intraerythrocytic proliferation, identified a novel parasite cyclin H homolog required for cytokinesis of blood-stage parasites, identified a essential contractile ring protein that controls cell division in P. falciparum, and developed a novel anti-parasitic compound that retains activity against artemisinin-resistant parasite strains.



      My recent clinical laboratory work includes evaluation of molecular and serological assays for the detection of Zika virus and Zika virus antibodies, and more recently evaluation and development of molecular and serological assays for the detection of SARS-CoV-2 and SARS-CoV-2 antibodies. Our early work has shown a significant link between the severity of patient symptoms and the subsequent immune response.


    Abstract

    Today's presentation will cover the following topics from the perspective of a NYC based Laboratory:

    • What have we learned year to date about CoV-2 and specifically how diagnostic testing has impacted where we are at today
    • Review role of  Molecular / Antigen testing (In lab and POC) for Covid-19
    • Experience with Serology testing YTD
    • What's needed moving forward

    Learning Objectives:

    1. Gain additional understanding on current testing options for Covid-19

    2. Understand options and pro's / con's for Covid-19 Antigen testing solutions


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more